Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men

NCT03103321 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT03103321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03103321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 3
Overall status
Completed
Start date
October 2, 2017
Completion date
November 25, 2020
Enrollment
158 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

psa level five to ten, psa level less than five, psa level ten to fifty, stage i prostate cancer, stage ii prostate cancer, stage iia prostate cancer, stage iib prostate cancer, stage iii prostate cancer